CLX Clorox
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products; Pine-Sol® cleaners; Liquid-Plumr® clog removers; Poett® home care products; Fresh Step® cat litter; Glad® bags and wraps; Kingsford® charcoal; Hidden Valley® dressings and sauces; Brita® water-filtration products; Burt's Bees® natural personal care products; and RenewLife®, Rainbow Light®, Natural Vitality Calm™, NeoCell® and Stop Aging Now® vitamins, minerals and supplements. The company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro™ and Clorox Healthcare® brand names. More than 80% of the company's sales are generated from brands that hold the No. 1 or No. 2 market share positions in their categories.
Company profile
Ticker
CLX
Exchange
Website
CEO
Benno Dorer
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
310595760
CLX stock data
()
News
JP Morgan Maintains Neutral on Clorox, Lowers Price Target to $196
16 Apr 21
Teen Vogue Drops New Editor As Advertisers Halt Campaigns Over Her Racist Tweets
18 Mar 21
Benzinga's Top Ratings Upgrades, Downgrades For March 18, 2021
18 Mar 21
DA Davidson Downgrades Clorox to Neutral, Announces $189 Price Target
18 Mar 21
Clorox Highlights Its 'Safer Today Alliance' In Collaboration With CDC And Cleveland Clinic To Provide Guidance To Companies On Safety And Sanitizing Measures
10 Mar 21
Press releases
The Clorox Company Named Official Partner of the Knicks, Rangers and Madison Square Garden Arena
6 Apr 21
Billy Porter and Clorox® Scentiva® Reinvent Spring Cleaning as Self-Care
30 Mar 21
Clorox Announces April 30 Webcast of Third Quarter Fiscal Year 2021 Results
30 Mar 21
Survey: Half of Canadians aren't confident public spaces are being properly disinfected
19 Mar 21
Clorox Launches a Collaborative Partnership with Cleveland Clinic and the CDC Foundation
10 Mar 21
Calendar
4 Feb 21
17 Apr 21
30 Jun 21
Financial summary
Quarter (USD) |
Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Annual (USD) |
Jun 20 | Jun 19 | Jun 18 | Jun 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Financial data from Clorox earnings reports.
| Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 737M | 737M | 737M | 737M | 737M | 737M |
| Cash burn (monthly) | 43.33M | (positive/no burn) | (positive/no burn) | (positive/no burn) | (positive/no burn) | (positive/no burn) |
| Cash used (since last report) | 154.73M | n/a | n/a | n/a | n/a | n/a |
| Cash remaining | 582.27M | n/a | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 13.4 | n/a | n/a | n/a | n/a | n/a |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Apr 21 | Reynolds Eric H | Common Stock | Sell | Dispose S | No | Yes | 193.0353 | 1,015 | 195.93K | 13,127 |
| 31 Mar 21 | Fleischer Spencer C | Common Stock | Grant | Aquire A | No | No | 192.88 | 159 | 30.67K | 774 |
| 31 Mar 21 | Paul Gray Parker | Common Stock | Grant | Aquire A | No | No | 192.88 | 33 | 6.37K | 33 |
| 31 Mar 21 | Kathryn A Tesija | Deferred Stock Units Common Stock | Grant | Aquire A | No | No | 0 | 133.503 | 0 | 834.359 |
| 31 Mar 21 | Shattock Matthew J | Deferred Stock Units Common Stock | Grant | Aquire A | No | No | 0 | 246.915 | 0 | 3,811.315 |
| 12 Feb 21 | Fleischer Spencer C | Deferred Stock Units Common Stock | Grant | Aquire A | No | No | 0 | 56.382 | 0 | 9,502.624 |
| 12 Feb 21 | Kathryn A Tesija | Deferred Stock Units Common Stock | Grant | Aquire A | No | No | 0 | 4.158 | 0 | 700.856 |
| 12 Feb 21 | Shattock Matthew J | Deferred Stock Units Common Stock | Grant | Aquire A | No | No | 0 | 21.149 | 0 | 3,564.4 |
Institutional ownership Q4 2020
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
82.7% owned by funds/institutions
13F holders |
Current |
|---|---|
| Total holders | 1226 |
| Opened positions | 152 |
| Closed positions | 105 |
| Increased positions | 410 |
| Reduced positions | 447 |
13F shares |
Current |
|---|---|
| Total value | 21B |
| Total shares | 104.01M |
| Total puts | 1.51M |
| Total calls | 1.28M |
| Total put/call ratio | 1.2 |
Largest owners |
Shares | Value |
|---|---|---|
| Vanguard | 15.32M | $3.09B |
| BLK Blackrock | 11.97M | $2.42B |
| STT State Street | 7.4M | $1.49B |
| WFC Wells Fargo & Co. | 3.54M | $715.64M |
| Geode Capital Management | 2.41M | $485.67M |
| NTRS Northern Trust | 2.1M | $423.87M |
| Parnassus Investments | 2.07M | $418.21M |
| Cedar Rock Capital | 1.92M | $388.39M |
| Renaissance Technologies | 1.66M | $334.24M |
| Aqr Capital Management | 1.61M | $323.98M |
Financial report summary
?Management Discussion
- (1) This represents the net impact on net sales growth / (decrease) from pricing actions, mix and other factors.
- (2) Organic sales growth / (decrease) is defined as net sales growth / (decrease) excluding the effect of any acquisitions and divestitures as well as changes in foreign exchange rates. See “Non-GAAP Financial Measures” below for reconciliation of organic sales growth / (decrease) to net sales growth, the most directly comparable GAAP financial measure.
- (3) Organic volume represents volume excluding the effect of any acquisitions and divestitures. In the three months ended December 31, 2020, the volume impact of acquisitions was 7% and 1% for International and Total Company, respectively. In the six months ended December 31, 2020, the volume impact of acquisitions was 7% and 1% for International and Total Company, respectively.
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
adapt, declined, inside, insignificant, replenishment, unissued, usage
Removed:
largely, timing
Financial reports
10-Q
2021 Q2
Quarterly report
4 Feb 21
10-Q
2021 Q1
Quarterly report
2 Nov 20
10-K
2020 FY
Annual report
13 Aug 20
10-Q
2020 Q3
Quarterly report
1 May 20
10-Q
2020 Q2
Quarterly report
4 Feb 20
10-Q
2020 Q1
Quarterly report
31 Oct 19
10-K
2019 FY
Annual report
13 Aug 19
10-Q
2019 Q3
Quarterly report
1 May 19
10-Q
2019 Q2
Quarterly report
4 Feb 19
10-Q
2019 Q1
Quarterly report
31 Oct 18
Current reports
8-K
Departure of Directors or Certain Officers
8 Apr 21
8-K
Other Events
16 Feb 21
8-K
Clorox Reports Q2 Fiscal Year 2021 Results, Updates Fiscal Year Outlook
4 Feb 21
8-K
Clorox Announces Changes to Board of Directors
28 Jan 21
8-K
Departure of Directors or Certain Officers
19 Nov 20
8-K
Longtime Finance Leader and Life Sciences Executive Paul Parker Elected to Clorox Board
18 Nov 20
8-K
Clorox Reports Q1 Fiscal Year 2021 Results, Updates Fiscal Year Outlook
2 Nov 20
8-K
Departure of Directors or Certain Officers
12 Aug 20
8-K
Clorox Reports Q4 and Fiscal Year 2020 Results, Provides Fiscal Year 2021 Outlook
3 Aug 20
8-K
Other Events
8 May 20
Registration and prospectus
424B2
Prospectus for primary offering
6 May 20
FWP
Free writing prospectus
5 May 20
424B3
Prospectus supplement
5 May 20
424B2
Prospectus for primary offering
8 May 18
FWP
Free writing prospectus
7 May 18
424B3
Prospectus supplement
7 May 18
S-3ASR
Automatic shelf registration
7 May 18
424B2
Prospectus for primary offering
27 Sep 17
424B3
Prospectus supplement
25 Sep 17
FWP
Free writing prospectus
25 Sep 17
Proxies
DEFA14A
Additional proxy soliciting materials
29 Oct 20
DEFA14A
Additional proxy soliciting materials
20 Oct 20
DEFA14A
Additional proxy soliciting materials
6 Oct 20
DEF 14A
Definitive proxy
6 Oct 20
PRE 14A
Preliminary proxy
25 Sep 20
DEFA14A
Additional proxy soliciting materials
6 Nov 19
DEFA14A
Additional proxy soliciting materials
29 Oct 19
DEFA14A
Additional proxy soliciting materials
2 Oct 19
DEF 14A
Definitive proxy
2 Oct 19
PRE 14A
Preliminary proxy
20 Sep 19
Other
SD
Conflict minerals disclosure
27 May 20
SD
Conflict minerals disclosure
28 May 19
SD
Conflict minerals disclosure
29 May 18
SD
Conflict minerals disclosure
29 May 17
SD
Conflict minerals disclosure
26 May 16
UPLOAD
Letter from SEC
17 Feb 16
CORRESP
Correspondence with SEC
3 Feb 16
CORRESP
Correspondence with SEC
20 Jan 16
UPLOAD
Letter from SEC
14 Jan 16
SD
Conflict minerals disclosure
28 May 15
Ownership
4
CLOROX / Eric H Reynolds ownership change
7 Apr 21
4
CLOROX / CHRISTOPHER J WILLIAMS ownership change
2 Apr 21
4
CLOROX / RUSSELL J WEINER ownership change
2 Apr 21
4
CLOROX / Kathryn A Tesija ownership change
2 Apr 21
4
CLOROX / Matthew J Shattock ownership change
2 Apr 21
4
CLOROX / Paul Gray Parker ownership change
2 Apr 21
4
CLOROX / Spencer C Fleischer ownership change
2 Apr 21
4
CLOROX / Eric H Reynolds ownership change
9 Mar 21
SC 13G
CLOROX / STATE STREET ownership change
12 Feb 21
SC 13G/A
CLOROX / VANGUARD ownership change
10 Feb 21
Patents
APP
Utility
Nutrient Compositions Having Enhanced Bioavailability
4 Mar 21
Disclosed are nutrient compositions formulated to provide enhanced bioavailability when administered by or taken by a subject.
GRANT
Design
Bag
23 Feb 21
Inventors: Ranyi Zhu, Edward B. Tucker, Robert T. Dorsey, Jason R. Maxwell, Shaun T. Broering, Kyle T. Diehl, Sean Chang, Michael G. Borchardt
GRANT
Design
Film with pattern
2 Feb 21
Inventors: Ranyi Zhu, Jack A. MacPherson, Kenneth E. Cisek, Theodore J. Fish
GRANT
Design
Bag
2 Feb 21
Inventors: Theodore Cory Fites, Ranyi Zhu
APP
Utility
Container Assembly
14 Jan 21
A container assembly is disclosed.
Transcripts
2021 Q2
Earnings call transcript
5 Feb 21
2021 Q1
Earnings call transcript
2 Nov 20
2021 Q1
Earnings call transcript
2 Nov 20
2021 Q1
Earnings call transcript
2 Nov 20
2020 Q4
Earnings call transcript
3 Aug 20
2020 Q3
Earnings call transcript
1 May 20
2020 Q2
Earnings call transcript
4 Feb 20
2020 Q1
Earnings call transcript
31 Oct 19
2019 Q4
Earnings call transcript
1 Aug 19
2019 Q3
Earnings call transcript
1 May 19
Reddit threads
5 Companies to set-and-forget hold for 10 years+
16 Apr 21
Daily General Discussion and spitballin thread - April 11, 2021
11 Apr 21
Weekly Recap - Dividend Aristocrats
10 Apr 21
Weekly Advice and Earnings Megathread
9 Apr 21
Working Through Overdiversification - Consumer Staples
9 Apr 21
r/Stocks Daily Discussion & Fundamentals Friday Apr 09, 2021
9 Apr 21
Open interest for Leaps trades
4 Apr 21
Weekly Update - Dividend Aristocrats
1 Apr 21
Is a dividend portfolio worth it when young?
28 Mar 21
Overcomplicating Dividend Portfolio?
23 Mar 21